Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
MicrobiotiX Logo
MicrobiotiX Growth Score
71
CB Rank
55814
Heat Score
52
MicrobiotiX develops bacteriophage and microbiome-based therapeutics to combat multidrug-resistant infections and autoimmune diseases.
Founded
obfuscation
PrivateSeries B Seoul, Seoul-t'ukpyolsi, South Korea11-50 microbiotix.net/
Biotechnology
Health Care
Life Science
Pharmaceutical
Therapeutics
Overview

MicrobiotiX
Total Funding
obfuscation
Growth Score
71
Heat Score
52

Total Funding
obfuscation
obfuscation
Series B raised
obfuscation
Growth Score71
-11 pts
in past quarter
Heat Score 52
0 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About MicrobiotiX

CB Rank
55814
MicrobiotiX develops bacteriophage and microbiome-based therapeutics to combat multidrug-resistant infections and autoimmune diseases.
Founded
obfuscation
PrivateSeries B Seoul, Seoul-t'ukpyolsi, South Korea11-50 microbiotix.net/
Biotechnology
Health Care
Life Science
Pharmaceutical
Therapeutics

Funding Rounds

Series B
OBF
in
obfuscation
Grant
OBF
in
obfuscation
Series B
OBF
in
obfuscation

Key People

Details

Legal Name MicrobiotiX Co., Ltd.
Also Known As 마이크로바이오틱스, Microbiotics
Operating Status Active
Company Type For Profit
Founders  Dongeun Yong
About the Company
MicrobiotiX is a biopharmaceutical company that develops bacteriophage-based therapies. It offers treatment that uses viruses (called phages) to kill harmful bacteria, especially those that are resistant to antibiotics.
Phone Number +82 02.6379.2649
Contact Email mx@microbiotix.net
Predictions & Insights

Growth Insight

See this Growth Insight
MicrobiotiX is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Runway Speculation

Products & Services

Bacteriophage Therapeutics
Therapeutic products using bacteriophages to target multidrug-resistant gram-negative bacteria such as Pseudomonas aeruginosa, Acinetobacter baumannii, Klebsiella pneumoniae, and Escherichia coli.
Bacteriophage Therapeutics
Therapies using bacteriophages to target multidrug-resistant gram-negative bacteria such as Pseudomonas aeruginosa, Acinetobacter baumannii, Klebsiella pneumoniae, and Escherichia coli.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 6
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - MicrobiotiX Logo
Series B - MicrobiotiX
3
obfuscation
— Series B
obfuscation
Series B - MicrobiotiX Logo
Series B - MicrobiotiX
3
obfuscation
— Series B
obfuscation
Series B - MicrobiotiX Logo
Series B - MicrobiotiX
3
obfuscation
— Series B
obfuscation
Series B - MicrobiotiX Logo
Series B - MicrobiotiX
3
obfuscation
— Series B
obfuscation
Series B - MicrobiotiX Logo
Series B - MicrobiotiX
3
obfuscation
— Series B

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 6
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - MicrobiotiX Logo
Series B - MicrobiotiX
3
obfuscation
— Series B
obfuscation
Series B - MicrobiotiX Logo
Series B - MicrobiotiX
3
obfuscation
— Series B
obfuscation
Series B - MicrobiotiX Logo
Series B - MicrobiotiX
3
obfuscation
— Series B
obfuscation
Series B - MicrobiotiX Logo
Series B - MicrobiotiX
3
obfuscation
— Series B
obfuscation
Series B - MicrobiotiX Logo
Series B - MicrobiotiX
3
obfuscation
— Series B

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Otium Capital Logo
Otium Capital
—
Series B - MicrobiotiX Logo
Series B - MicrobiotiX
—
Otium Capital Logo
Otium Capital
—
Series B - MicrobiotiX Logo
Series B - MicrobiotiX
—
Otium Capital Logo
Otium Capital
—
Series B - MicrobiotiX Logo
Series B - MicrobiotiX
—
Otium Capital Logo
Otium Capital
—
Series B - MicrobiotiX Logo
Series B - MicrobiotiX
—
Otium Capital Logo
Otium Capital
—
Series B - MicrobiotiX Logo
Series B - MicrobiotiX
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 1

Employee Profiles

News

News and Press

News•Nov 20, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Oct 27, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Sep 3, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Sep 3, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

1,676
444.16%
 in past month

Active Website Tech Count

3MicrobiotiX is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 50m, and  Dash.js.

Total IP

5The intellectual property of MicrobiotiX includes 5 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is MicrobiotiX's headquarters? MicrobiotiX is located in Seoul, Seoul-t'ukpyolsi, South Korea.Who invested in MicrobiotiX? MicrobiotiX has 14 investors including Otium Capital and  Paratus Investment.When was the last funding round for MicrobiotiX? MicrobiotiX closed its last funding round on
obfuscation
from a Series B round.Who are MicrobiotiX's competitors? Alternatives and possible competitors to MicrobiotiX may include Ferring, Eligo Bioscience, and  Seres Therapeutics.How much funding has MicrobiotiX raised to date? MicrobiotiX has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|